DataM resources that are widely useful for your reference. We have curated special links for you to browse through

Taiwan’s expanding AI data center infrastructure, semiconductor manufacturing capacity and grid modernization programs are creating a multi-year demand cycle for electrical equipment. This analysis examines the implications of Taiwan’s revised 2.5% annual electricity-demand growth forecast for 2026–2035, the projected increase in AI computing load from approximately 60 MW to 450 MW by 2029, and Taipower’s NT$564.5 billion grid resilience program. It assesses transformer and switchgear order visibility extending into 2029–2030, manufacturing capacity constraints, GIS and cable procurement, skilled installation labor shortages, and emerging 800V HVDC power distribution requirements.
October 23, 2026

The global TL1A antagonist therapy market is gaining attention as pharmaceutical companies advance targeted treatments for ulcerative colitis, Crohn’s disease and other immune-mediated conditions. This company analysis profiles 10 key players: Merck & Co., Roche, Sanofi, Teva Pharmaceutical Industries, AbbVie, Pfizer, Boehringer Ingelheim, Xencor, Spyre Therapeutics and Absci. It examines their competitive positioning, pipeline assets, clinical development strategies, corporate revenues, partnerships and recent innovation milestones.
October 23, 2026

Explore the top 10 companies shaping the global data center power infrastructure market as AI workloads, high-density computing and grid constraints accelerate demand for integrated power solutions. According to DataM Intelligence, the market is estimated at US$21.74 billion in 2025 and is projected to reach US$87.1 billion by 2035. This competitive analysis examines Vertiv, Schneider Electric, Eaton, ABB, Siemens, Legrand, Caterpillar, Ecolab/CoolIT Systems, SLB/Kelvion and Rittal.
October 16, 2026